TEL AVIV, Israel, June 17, 2013 /PRNewswire/ --
Breezy, a portfolio company of The Trendlines Group, launched their first product this week using a platform technology enabling innovative treatment of mouth-cavity conditions. LIKE, a confectionary-based product which combats halitosis (bad breath) is being sold in major Israeli pharmacy chains and will reach a distribution of 650 stores. This commercial launch in Israel follows similar successful product launches in France and Spain earlier this year, with a repeat order from the French market.
Almost 50% of the adult population suffers from bad breath, caused mainly by bacteria that reside on the tongue, particularly towards the back of the mouth. Another percentage of the population suffers from bad breath due to smoking, medications (chemotherapy), dry mouth and more. While many products currently on the market attempt to combat this problem; their efficacy is limited. Either the products have a short-term effect, cover up the problem, kill good bacteria or are inconvenient and unpleasant to use.
The LIKE product is a unique confectionery-based lollipop, backed by clinical studies, that answers the problems of bad breath. It is proven as a safe, effective oral odor-neutralizing product. LIKE's triple-action formula scrubs the tongue using microcapsules, containing natural odor-neutralizing agents. The dissolved microcapsules release active agents to further combat bacteria for a long-lasting effect leaving a fresh taste of mint. As an on-the-go product, the LIKE product can be used anywhere and anytime.
"We are excited to have our product on the shelves and to receive overwhelmingly positive feedback from customers that it really works," said Hillel Lerman, CEO of Breezy.
Breezy is currently seeking partnerships with additional marketing channels to extend commercial distribution. In the future Breezy's developments will include additional products for smoker's breath, dry mouth, and candida on the tongue.
Ofir Shpigel Media and Public Relations
Copyright©2012 PR Newswire.
All rights reserved